1. Home
  2. CTOR vs ARMP Comparison

CTOR vs ARMP Comparison

Compare CTOR & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTOR
  • ARMP
  • Stock Information
  • Founded
  • CTOR 2021
  • ARMP N/A
  • Country
  • CTOR United States
  • ARMP United States
  • Employees
  • CTOR N/A
  • ARMP N/A
  • Industry
  • CTOR
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CTOR
  • ARMP Health Care
  • Exchange
  • CTOR NYSE
  • ARMP Nasdaq
  • Market Cap
  • CTOR 89.9M
  • ARMP 80.0M
  • IPO Year
  • CTOR N/A
  • ARMP N/A
  • Fundamental
  • Price
  • CTOR $1.23
  • ARMP $1.95
  • Analyst Decision
  • CTOR Strong Buy
  • ARMP Strong Buy
  • Analyst Count
  • CTOR 2
  • ARMP 1
  • Target Price
  • CTOR $4.50
  • ARMP $7.00
  • AVG Volume (30 Days)
  • CTOR 78.9K
  • ARMP 7.3K
  • Earning Date
  • CTOR 02-21-2025
  • ARMP 03-20-2025
  • Dividend Yield
  • CTOR N/A
  • ARMP N/A
  • EPS Growth
  • CTOR N/A
  • ARMP N/A
  • EPS
  • CTOR N/A
  • ARMP N/A
  • Revenue
  • CTOR N/A
  • ARMP $5,467,000.00
  • Revenue This Year
  • CTOR N/A
  • ARMP $23.87
  • Revenue Next Year
  • CTOR N/A
  • ARMP N/A
  • P/E Ratio
  • CTOR N/A
  • ARMP N/A
  • Revenue Growth
  • CTOR N/A
  • ARMP 34.92
  • 52 Week Low
  • CTOR $0.85
  • ARMP $1.80
  • 52 Week High
  • CTOR $49.00
  • ARMP $4.48
  • Technical
  • Relative Strength Index (RSI)
  • CTOR N/A
  • ARMP 41.17
  • Support Level
  • CTOR N/A
  • ARMP $1.93
  • Resistance Level
  • CTOR N/A
  • ARMP $2.22
  • Average True Range (ATR)
  • CTOR 0.00
  • ARMP 0.11
  • MACD
  • CTOR 0.00
  • ARMP -0.01
  • Stochastic Oscillator
  • CTOR 0.00
  • ARMP 4.55

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: